Taiwan · Delayed Price · Currency is TWD Sinew Pharma Statistics
Total Valuation
Sinew Pharma has a market cap or net worth of TWD 3.15 billion. The enterprise value is 2.06 billion.
| Market Cap | 3.15B |
| Enterprise Value | 2.06B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Sinew Pharma has 71.32 million shares outstanding. The number of shares has increased by 0.12% in one year.
| Current Share Class | 71.32M |
| Shares Outstanding | 71.32M |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | -0.43% |
| Owned by Insiders (%) | 14.19% |
| Owned by Institutions (%) | 3.23% |
| Float | 45.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.75 |
| P/TBV Ratio | 2.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.54 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -21.17 |
Financial Position
The company has a current ratio of 53.40, with a Debt / Equity ratio of 0.02.
| Current Ratio | 53.40 |
| Quick Ratio | 53.34 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.19 |
| Interest Coverage | -794.35 |
Financial Efficiency
Return on equity (ROE) is -11.78% and return on invested capital (ROIC) is -8.20%.
| Return on Equity (ROE) | -11.78% |
| Return on Assets (ROA) | -8.07% |
| Return on Invested Capital (ROIC) | -8.20% |
| Return on Capital Employed (ROCE) | -13.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.96M |
| Employee Count | 52 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.02% in the last 52 weeks. The beta is -0.04, so Sinew Pharma's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | -20.02% |
| 50-Day Moving Average | 46.69 |
| 200-Day Moving Average | 48.97 |
| Relative Strength Index (RSI) | 35.77 |
| Average Volume (20 Days) | 36,748 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -159.67M |
| Pretax Income | -141.91M |
| Net Income | -141.91M |
| EBITDA | -137.49M |
| EBIT | -159.67M |
| Earnings Per Share (EPS) | -1.99 |
Balance Sheet
The company has 1.10 billion in cash and 18.03 million in debt, giving a net cash position of 1.09 billion or 15.22 per share.
| Cash & Cash Equivalents | 1.10B |
| Total Debt | 18.03M |
| Net Cash | 1.09B |
| Net Cash Per Share | 15.22 |
| Equity (Book Value) | 1.15B |
| Book Value Per Share | 16.06 |
| Working Capital | 1.11B |
Cash Flow
In the last 12 months, operating cash flow was -97.00 million and capital expenditures -469,000, giving a free cash flow of -97.47 million.
| Operating Cash Flow | -97.00M |
| Capital Expenditures | -469,000 |
| Free Cash Flow | -97.47M |
| FCF Per Share | -1.37 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Sinew Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.12% |
| Shareholder Yield | -0.12% |
| Earnings Yield | -4.51% |
| FCF Yield | -3.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |